Operating profits drop for Parexel thanks to restructuring costs Operating profits drop for Parexel thanks to restructuring costs 10-Aug-2011 By Natalie Morrison Restructuring costs for Parexel have caused a dramatic drop in GAAP operating income, reveal the company’s Q4 results.
Tereos Syral to add injectable glucose to range Tereos Syral to add injectable glucose to range 10-Aug-2011 Tereos Syral plans to add pyrogen-controlled glucose monohydrate production capacity to expand into pharmaceutical starch derivatives.
Akela plans CMO buys after exiting development project Akela plans CMO buys after exiting development project 10-Aug-2011 By Nick Taylor Akela Pharma is focusing on its CMO and expanding it through acquisitions after its partner exited their drug development programme.
eClinical results round-up eClinical results round-up 10-Aug-2011 By Nick Taylor Outsourcing-Pharma presents a round-up of eClinical quarterly results, including financials from Medidata, Perceptive Informatics, ERT and BioClinica.
Appointments at Akrimax, Vernalis, Sanofi and Pregis – People on the move Appointments at Akrimax, Vernalis, Sanofi and Pregis – People on the move 10-Aug-2011 By Natalie Morrison In-PharmaTechnologist presents its latest round-up of executive moves in the pharma industry, including appointments at Akrimax, Vernalis, Sanofi and Pregis.
Pfizer “aggressively” pursuing cost saving real-time release Pfizer “aggressively” pursuing cost saving real-time release 10-Aug-2011 By Nick Taylor Pfizer is “aggressively” moving toward real-time release (RTR) and believes return on investment can be realised in a year.